Initial Consultation
- History, medications, goals and prior attempts
- Lab and testing plan
- In person in Avon or by telehealth
A medical weight loss program that measures what the scale can’t. Labs, body composition and metabolic testing first, then medication when it’s right for you, and a clinician every 4 to 6 weeks.
BIOGENEX medical weight loss in Avon, CT combines a 100+ biomarker panel, InBody body composition and PNOĒ metabolic testing with GLP-1 medication such as tirzepatide when clinically appropriate. Check-ins every 4 to 6 weeks adjust dose, protein and training so you lose fat and protect muscle. It starts with an $89 consultation.
If you have done everything right and the weight still won’t move, something measurable is usually in the way. These are the patterns we find most often.
Two people can lose the same weight on the same medication. One loses mostly fat and keeps their strength. The other loses muscle, slows their metabolism and regains. The difference is measurement, protein and training, managed every 4 to 6 weeks.
Illustration of the goal, not a guaranteed outcome. InBody tracks your actual split at every milestone.
GLP-1 medications mimic gut hormones that tell your brain you are full and help your body handle sugar. In large clinical trials, the benefits reach well beyond the scale.
Three generations of the same idea, each acting on more of the hormones that regulate hunger, blood sugar and energy use. Here is what the clinical trials show.
| Semaglutide | Tirzepatide | Retatrutide | |
|---|---|---|---|
| Acts on | GLP-1 | GIP + GLP-1 | GIP + GLP-1 + glucagon |
| Dosing | Once weekly | Once weekly | Once weekly |
| Pivotal trial | STEP-1 · 68 weeks | SURMOUNT-1 · 72 weeks | TRIUMPH-1 · 80 weeks |
| Average weight loss | 14.9% (2.4 mg) | 20.9% (15 mg) | 28.3% (12 mg) |
| Head-to-head | 13.7% in SURMOUNT-5 | 20.2% in SURMOUNT-5 | Not yet compared directly |
| Standout data | Cardiovascular protection (SELECT) | Sleep apnea, insulin sensitivity | 30.3% at 104 weeks; 28.7% in TRIUMPH-4 |
Results are averages from separate trials with different populations and durations, except SURMOUNT-5, which compared tirzepatide and semaglutide directly. Common side effects for all three are nausea, diarrhea and constipation, usually during dose increases. Individual results vary.
100+ biomarkers including insulin, A1c, leptin, adiponectin, thyroid and sex hormones, plus InBody composition and PNOĒ resting metabolic rate.
GLP-1 medication when clinically appropriate, with hormone, thyroid and sleep issues addressed alongside it.
Protein and resistance-training targets built from your lean mass, so the weight you lose is fat.
Check-ins every 4 to 6 weeks: dose, side effects, InBody and nutrition adjusted to your data, then a planned taper.
| BIOGENEX program | Online GLP-1 service | Diet on your own | |
|---|---|---|---|
| Labs before treatment | 100+ biomarkers | Questionnaire | None |
| Body composition | InBody at every milestone | Scale weight | Scale weight |
| Metabolic testing | PNOĒ resting metabolic rate | None | App estimate |
| Muscle protection | Protein and training targets | Rarely addressed | Rarely addressed |
| Clinician contact | Every 4–6 weeks, same clinician | Asynchronous | None |
| Root causes | Thyroid, hormones, insulin, sleep | Not assessed | Not assessed |
Laboratory charges are billed separately.

Functional nutrition, metabolic medicine and hormone optimization in one clinician, who looks at the whole system instead of a single number on the scale.
“When I first started working with him, I wasn’t feeling my best, and he took the time to understand what was really going on rather than just treating symptoms.”
“For me being in my 40s and feeling like I’m in my 20s was very important… If you are serious about your health and want real service look no further.”
Can’t find your question? Call 959-204-5375 or ask at your consultation.
It starts with an $89 consultation and a 100+ biomarker panel, InBody body composition and, where useful, PNOĒ resting metabolic rate testing. Your clinician then builds a plan that may include GLP-1 medication such as tirzepatide when clinically appropriate, protein and training targets to protect muscle, and check-ins every 4 to 6 weeks to adjust dose and nutrition.
GLP-1 receptor agonists such as semaglutide, and dual GIP/GLP-1 agonists such as tirzepatide, reduce appetite, slow stomach emptying and improve blood sugar control. They are prescription medications that require clinical evaluation and monitoring.
When clinically appropriate, BIOGENEX prescribes FDA-approved GLP-1 medication such as tirzepatide. The right choice depends on your history, labs, goals, prior response and how you tolerate the medication, and the dose is adjusted at each check-in. If you want to learn more about a specific GLP-1 compound and which one is best for you, book your $89 consultation.
Both work. Tirzepatide acts on two hormone receptors (GIP and GLP-1) and produced more weight loss in the head-to-head SURMOUNT-5 trial: an average of 20.2% of body weight at 72 weeks, versus 13.7% with semaglutide. Semaglutide has the largest cardiovascular outcome data, including a 20% reduction in major cardiac events in the SELECT trial. Your clinician weighs both against your history and goals.
Retatrutide is a once-weekly triple agonist that acts on GIP, GLP-1 and glucagon receptors. In the phase 3 TRIUMPH-1 trial, adults without diabetes lost an average of 28.3% of body weight at 80 weeks on the 12 mg dose, and 30.3% at 104 weeks in an extension group. It is still investigational and in clinical trials. Ask about it at your consultation and we will walk you through the latest data.
Some of the weight lost on any calorie deficit can come from lean mass. BIOGENEX tracks body composition with InBody at every milestone and sets protein and resistance-training targets so the weight you lose is mostly fat.
Thyroid dysfunction, insulin resistance, low testosterone, perimenopause and high cortisol can all make weight loss harder. Testing 100+ biomarkers first means the plan addresses the cause, not only appetite.
The initial consultation is $89. Program pricing depends on the medication and plan chosen and is set at your consultation. Laboratory charges are billed separately. Weight loss members receive 20% off PNOĒ metabolic testing, which starts at $150.
Clinician check-ins happen every 4 to 6 weeks during active treatment, with dose, side effects, InBody results and nutrition reviewed each time.
Weight regain is common after stopping GLP-1 medication without a plan. BIOGENEX uses the treatment period to build muscle, habits and metabolic data, then tapers and adjusts with you rather than stopping abruptly.
Yes. Consultations and check-ins are available by telehealth across Connecticut and in other states where the treating clinician is licensed. InBody and PNOĒ testing are done in person at 51 East Main St, Avon, CT.
Online services usually send a prescription after a questionnaire. BIOGENEX starts with labs and body composition, sees you every 4 to 6 weeks, protects muscle, and treats the hormonal and metabolic causes behind weight gain.
Educational information, not a diagnosis. Medication is prescribed only when clinically appropriate. Individual results vary.
BIOGENEX is at 51 East Main St, Avon, CT 06001, in the Farmington Valley, about 20 minutes from Hartford and West Hartford. Patients come in person from across Hartford County and Fairfield County. Telehealth care is available throughout Connecticut and in other states where the treating clinician is licensed; labs are drawn at a local site near you.